Psychedelic Alpha’s Medical Advisor, Michael Haichin, compiled a list of over 500 notable psychedelics-related publications from 2024. He then presented it to a group of researchers from varying…

Szigeti discusses expectancy effects, unblinding, and how researchers might design better studies on psychedelics.

This narrative review discusses the impact of expectancy effects and functional unblinding on treatment responses in randomized clinical trials of treatments in psychiatry.

We present the psychedelic drug development pipeline in a ‘bullseye chart’ format, as of Q1’25.

Renewed interest in psychedelics as treatments for mental disorders has recently emerged, but substantial challenges remain in obtaining evidence from available data to inform clinical decision-making...

We need a new language to talk about the chemicals and plants that change our consciousness.

In our latest Pα+ interview, our Editor Josh Hardman speaks with Javier Muniz, MD, who recently left his post as Associate Director at the FDA’s Division of Psychiatry. In that role, Muniz was at the…

Subscription and open access journals from Sage, the world's leading independent academic publisher.

Subscription and open access journals from Sage, the world's leading independent academic publisher.

Subscription and open access journals from Sage, the world's leading independent academic publisher.

YouTube video by Louisiana Channel

PDF | Background: Psychedelic drugs show promise in facilitating a variety of long-term psychological changes, but they may also lead to unexpected... | Find, read and cite all the research you need o...

Psychedelic Alpha’s Medical Advisor, Michael Haichin, compiled a list of over 500 notable psychedelics-related publications from 2023. He then presented it to a group of researchers from varying…